Calidi Biotherapeutics, Inc. – AMEX:CLDI
Calidi Biotherapeutics stock price today
Calidi Biotherapeutics stock price monthly change
Calidi Biotherapeutics stock price quarterly change
Calidi Biotherapeutics key metrics
Market Cap | 24.97M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | N/A |
Revenue | N/A |
EBITDA | N/A |
Income | N/A |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeCalidi Biotherapeutics stock price history
Calidi Biotherapeutics stock forecast
Calidi Biotherapeutics financial statements
| 2020 | 0 | -7.93M | |
|---|---|---|---|
| 2023 | 0 | -29.21M |
| 2023-11-14 | -0.17 | -0.14 |
|---|---|---|
| 2024-03-19 | -0.2 | -0.48 |
| 2024-05-14 | -0.27 | -0.2 |
| 2023 | 10019000 | 18.25M | 182.19% |
|---|
| 2022 | -13.21M | -494K | 12.08M |
|---|---|---|---|
| 2023 | -26.98M | -478K | 29.04M |
Calidi Biotherapeutics alternative data
| Jun 2024 | 41 |
|---|---|
| Jul 2024 | 41 |
| Dec 2024 | 41 |
Calidi Biotherapeutics other data
| Period | Buy | Sel |
|---|---|---|
| Dec 2024 | 0 | 10000 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Sale | CAMAISA ALLAN director, officer: CEO and Chai.. | Common Stock | 10,000 | $1.62 | $16,200 | ||
Option | SCHOENECK JAMES A director | Common Stock | 375,000 | $0.2 | $75,000 | ||
Option | SCHOENECK JAMES A director | Common Stock | 375,000 | $0.2 | $75,000 | ||
Option | SCHOENECK JAMES A director | Common Stock | 173,000 | $0.2 | $34,600 | ||
Option | SCHOENECK JAMES A director | Common Stock | 173,000 | $0.2 | $34,600 | ||
Option | SCHOENECK JAMES A director | Warrants | 375,000 | $0.2 | $75,000 | ||
Option | SCHOENECK JAMES A director | Warrants | 375,000 | $0.2 | $75,000 | ||
Option | SCHOENECK JAMES A director | Warrants | 173,000 | $0.2 | $34,600 | ||
Option | SCHOENECK JAMES A director | Warrants | 173,000 | $0.2 | $34,600 | ||
Option | SCHOENECK JAMES A director | Warrants | 173,000 | $0.2 | $34,600 |
-
What's the price of Calidi Biotherapeutics stock today?
One share of Calidi Biotherapeutics stock can currently be purchased for approximately $2.93.
-
When is Calidi Biotherapeutics's next earnings date?
Unfortunately, Calidi Biotherapeutics's (CLDI) next earnings date is currently unknown.
-
Does Calidi Biotherapeutics pay dividends?
No, Calidi Biotherapeutics does not pay dividends.
-
How much money does Calidi Biotherapeutics make?
Calidi Biotherapeutics has a market capitalization of 24.97M. Calidi Biotherapeutics made a loss 29.22M US dollars in net income (profit) last year or -$0.2 on an earnings per share basis.
-
What is Calidi Biotherapeutics's stock symbol?
Calidi Biotherapeutics, Inc. is traded on the AMEX under the ticker symbol "CLDI".
-
What is Calidi Biotherapeutics's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Calidi Biotherapeutics?
Shares of Calidi Biotherapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Calidi Biotherapeutics have?
As Dec 2024, Calidi Biotherapeutics employs 41 workers.
-
When Calidi Biotherapeutics went public?
Calidi Biotherapeutics, Inc. is publicly traded company for more then 3 years since IPO on 1 Nov 2021.
-
What is Calidi Biotherapeutics's official website?
The official website for Calidi Biotherapeutics is calidibio.com.
-
Where are Calidi Biotherapeutics's headquarters?
Calidi Biotherapeutics is headquartered at 4475 Executive Drive, San Diego, CA.
-
How can i contact Calidi Biotherapeutics?
Calidi Biotherapeutics's mailing address is 4475 Executive Drive, San Diego, CA and company can be reached via phone at 858 794 9600.
Calidi Biotherapeutics company profile:
Calidi Biotherapeutics, Inc.
calidibio.comAMEX
41
Biotechnology
Healthcare
Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, engages in developing immunotherapies for the treatment of cancer. It engages in advancing a potent allogeneic stem cell capable of carrying an anti-tumor payload for use in multiple oncology indications, including high-grade gliomas and solid tumors. The company's cell-based delivery platforms are designed to protect, amplify, and potentiate oncolytic viruses leading to enhanced efficacy and improved patient safety. Its pipeline of products candidates in the clinic includes NeuroNova that are allogeneic neural stem cells loaded with an oncolytic adenovirus for the treatment of high-grade gliomas; and SuperNova, which are allogeneic adipose-derived mesenchymal stem cells loaded with tumor-selective CAL1 oncolytic vaccinia virus for the treatment of advanced metastatic solid tumors. The company was founded in 2014 and is based in San Diego, California.
San Diego, CA 92121
CIK: 0001855485
ISIN: US3207031010
:
